Quick Answer
Forte Biosciences, Inc. reported Total Assets of $82.78 million for fiscal year 2025.
Forte Biosciences, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $82.78M | +34.5% |
| 2024 | $61.56M | +57.9% |
| 2023 | $38.98M | -7.2% |
| 2022 | $42.00M | -3.0% |
| 2021 | $43.31M | -29.3% |
| 2020 | $61.24M | +699.7% |
| 2019 | $7.66M | -92.6% |
| 2018 | $103.08M | +12.0% |
| 2017 | $92.07M | +160.5% |
| 2016 | $35.35M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $97.09M | +441.0% | -9.9% |
| June 30, 2025 | $107.78M | +313.3% | +127.1% |
| March 31, 2025 | $47.46M | +48.2% | -22.9% |
| December 31, 2024 | $61.56M | +57.9% | +243.0% |
| September 30, 2024 | $17.95M | -62.5% | -31.2% |
| June 30, 2024 | $26.08M | -16.4% | -18.5% |
| March 31, 2024 | $32.02M | -12.8% | -17.9% |
| December 31, 2023 | $38.98M | -7.2% | -18.6% |
- Forte Biosciences, Inc. showed an increase of +34.5% in Total Assets compared to the prior fiscal year.
- Over the 2016–2025 period, Forte Biosciences, Inc.’s total assets has grown by 134.2% (from $35.35 million to $82.78 million).
- The most recent figure is from Forte Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: